BDEW calls for new medicine strategy for Germany from manufacturer to consumer

BDEW calls for new medicine strategy for Germany from manufacturer to consumer

MEDUWA shows the way: In order to reduce pharmaceuticals in the environment, involve actors along the value chain and, in addition to the disposal level, also address the production and application levels.

Here is an German article of Zeit online (22 October 2018) on a BDEW (Bundesverband der deutschen Energie- und Wasserwirtschaft) study on economic instruments for reducing pharmaceuticals to cover the so-called fourth clarification stage. “In addition to the fourth clarification stage, it is necessary to develop a “new medicine strategy for Germany from manufacturer to consumer”, writes BDEW. According to the report, the pollution of water bodies by medicine residues will increase in the future. Reasons for this are the ageing of society and an increasing per capita consumption of pharmaceuticals. Medicine residues do not always originate from human pharmaceuticals, but agriculture contributes to water pollution too, for example through the excessive spreading of liquid manure”.

One Comment

Leave a Reply

Your email address will not be published. Required fields are marked *